"Neuroleptic malignant syndrome" (NMS) derives from the French ... vigilance and expertise is required in order to diagnose and initiate treatment of NMS promptly. A number of risk factors ...
Yet, clinicians treating persons with autism continue to prescribe older neuroleptic agents targeting ... of tardive dyskinesia and neuroleptic malignant syndrome. This article presents a model ...
A Clinicians' Guide to Diagnosis and Treatment' is an apt description. Since the severe, life-threatening forms of catatonia are infrequent, this book will serve as an excellent source for ...
Medically reviewed by Brigid Dwyer, MD Compazine (prochlorperazine) is a prescription drug approved for the treatment of ...
Discontinue if neuroleptic malignant syndrome occurs or if DRESS is suspected ... monitor CBCs during 1 st few months of treatment; discontinue if WBCs decline. Perform fall risk assessments ...
used in the treatment of malignant hyperpyrexia and hyperthermia, neuroleptic malignant syndrome and hypercatabolic syndrome. This important new series arises from a coordinated programme of the ...
Exclude neuroleptic malignant syndrome if fever or other symptoms ... monitor CBCs during 1 st few months of treatment; discontinue if WBCs decline. Hepatic dysfunction. Seizure risk.